Results 101 to 110 of about 1,825 (197)

Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema

open access: yesInternational Journal of Nanomedicine, 2019
Shanshan Gao, Baocheng Tian, Jingtian Han, Jing Zhang, Yanan Shi, Qingzhi Lv, Keke LiSchool of Pharmacy, Binzhou Medical University, Yantai, People’s Republic of chinaBackground: Nanostructured lipid carriers (NLCs) are emerging as attractive drug ...
Gao S   +6 more
doaj  

AI-Assisted Pharmaceutical Formulation Design: Comparative Development and Experimental Evaluation of Sustained-Release Lornoxicam Tablets. [PDF]

open access: yesPharmaceuticals (Basel)
Abdulkarim M   +8 more
europepmc   +1 more source

Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam. [PDF]

open access: yesDrugs R D
Liu Y   +7 more
europepmc   +1 more source

Local Wound Infiltration for Thyroidectomized Patients in the Era of Multimodal Analgesia. [PDF]

open access: yesMedicina (Kaunas), 2023
Laskou S   +6 more
europepmc   +1 more source

Efficacy of Lornoxicam as a Pre-emptive Analgesic in Mandibular Third Molar Surgery - A Comparative Study. [PDF]

open access: yesAnn Maxillofac Surg, 2023
Kaila V   +5 more
europepmc   +1 more source

Opposite effects of lornoxicam co-administration on phenprocoumon pharmacokinetics and pharmacodynamics

open access: yes, 1999
OBJECTIVE: To investigate the effect of co-administration of the non-steroidal anti-inflammatory drug (NSAID) lornoxicam on the pharmacokinetics of (R)- and (S)-phenprocoumon and their effect on factor II and VII activities.
von Felten, A.   +4 more
core  

Home - About - Disclaimer - Privacy